An Open-Label Pharmacodynamic Study of Bevacivumab and Pazopanib in Renal Cell Carcinoma
Status:
Completed
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
This study will determine whether blood tests, tumour imaging and tumour tissue analysis can
reveal effects of drugs that block blood vessel growth (angiogenesis) in patients with renal
cancer.